Device Trial Radar · NCT01510392
CEI Van Outreach Screening Study
Last checked: Nov 19, 2026Latest source record: Apr 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
118
Actual
Start
Jan 2012
Primary completion
Feb 2, 2017
Study completion Feb 2, 2017
Sponsor
- Lead sponsor
- Oregon Health and Science UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Eye Institute (NEI)
- First posted
- Jan 16, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 89 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).
Conditions
- Glaucoma
- Macular Disease
- Keratoconus
Interventions
OCT imaging, the FDA Cleared iVueDevice
The OCT system scans a beam of light across the eye to take a picture. OCT imaging does not touch the eye. This is a test that is performed using an FDA approved system, and is regularly used to take pictures of the back of the eye.
Primary outcomes
What the sponsor says the trial is designed to measure.
- OCT screening efficacy for detection of early stage eye diseases in comparison to the current standard of care methodsTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Casey Eye Institute Outreach Screening Van
Portland, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.